Publicacions
-
Mora J, Climent A, Roldan-Molina M, Flores MC, Varo A, Pérez-Jaume S, Jou-Munoz C, Celma MS, Lazaro JJ, Cheung I, Castañeda-Heredia A, Gorostegui M, Rodriguez E, Chamorro S, Muñoz JP and Cheung NK.
Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects
Frontiers in oncology . 14: 1380917-1380917.
-
Nieva G, Agulló N, Grande-Molina M, Adell NE, Tarrado X, Calvo-Duarte L, Valls-Esteve A, Krauel L, Fenollosa-Artés F, Teixidó R and Borròs S.
Developing tuneable viscoelastic silicone gel-based inks for precise 3D printing of clinical phantoms
Materials Advances . 5(9): 3706-3720. Nº de cites: 2
-
Gorostegui M, Muñoz JP, Pérez-Jaume S, Simao-Rafael M, Cristina Larrosa Espinosa, Garraus-Oneca M, Salvador-Marcos N, Lavarino C, Krauel L, Mañe S, Castañeda-Heredia A and Mora J.
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy
Cancers . 16(9): . Nº de cites: 1
-
Fresno Cañada C, Gispets Parcerisas J, Del Prado-Sanchez C, Puigventós E, Pérez-Jaume S, Salvador-Hernandez H, Llorca Cardeñosa A and Prat-Bartomeu J.
DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1.
Heliyon . 10(8): .
-
Pasten A, Salvador-Alarcon C, Mora J, Martín Gimenez MP, Carrasco-Torrents R and Krauel L.
Current Status of Fertility Preservation in Pediatric Oncology Patients.
CHILDREN-BASEL . 11(5): . Nº de cites: 1
-
Mora J, Modak S, Kinsey J, Ragsdale CE and Lazarus HM.
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma
INTERNATIONAL JOURNAL OF CANCER . 154(8): 1340-1364. Nº de cites: 6
-
Llurba E, Fàtima Crispi Brillas, Crovetto F, Youssef L, Delgado JL, Puig I, Mora J, Krofta L, Mackova K, Martinez-Varea A, Tubau A, Ruiz-Llobet A, Paya A, Prat M, Chantraine F, Comas C, Kajdy A, Lopez-Tinajero MF, Figueras-Retuerta F and Gratacós E.
Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study.
BMJ Open . 14(3): . Nº de cites: 1
-
Villasante A, Corominas J, Alcon C, Garcia-Lizarribar A, Mora J, Lopez-Fanarraga M and Samitier J.
Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model
Cancers . 16(5): . Nº de cites: 1
-
Chantada L, Gorostegui M, Lowe J, Ranasinghe N, Villegas L, Geel J, Howard S, Bouffet E, Chantada G, Challinor J and Cappellano A.
SIOP pediatric oncology services Global Mapping Program: Latin American data collection
PEDIATRIC BLOOD & CANCER . 71(2): . Nº de cites: 2
-
Valls-Esteve A, Tejo-Otero A, Adell NE, Lustig-Gainza P, Fenollosa-Artés F, Buj-Corral I, Rubio-Palau J, Munuera-del Cerro JL and Krauel L.
Advanced Strategies for the Fabrication of Multi-Material Anatomical Models of Complex Pediatric Oncologic Cases
BIOENGINEERING-BASEL . 11(1): . Nº de cites: 2